Clinical Trials

Breast Neoplasms

NCT00482755 2024-02-12

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

4 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00881361 2023-04-27

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer

756 enrolled 12 charts

Breast Neoplasms

NCT04249440 2020-09-28

Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer

Completed

1,067 enrolled

Breast Neoplasms

NCT01099436 2020-01-21

NEO-ZOTAC

250 enrolled

Breast Neoplasms

NCT01367288 2019-05-28

NEOZOL

53 enrolled

Breast Neoplasms, Neovascularization, Pathologic

NCT00788112 2017-08-07

Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast

Phase 1 Completed

17 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00647218 2017-02-23

Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase NA Completed

38 enrolled

Breast Neoplasms

NCT00379015 2016-09-28

Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer

38 enrolled

Breast Neoplasms

NCT01293032 2016-07-12

Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

Phase NA Completed

59 enrolled 11 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00821886 2014-12-22

Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer

60 enrolled 5 charts

Breast Neoplasms

NCT00107211 2014-09-17

Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast

Phase 1 Completed

30 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00017095 2013-10-24

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

1,856 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00288002 2013-08-26

Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

1,500 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00427245 2013-08-07

Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer

400 enrolled

Breast Neoplasms, Infertility

NCT00978770 2013-08-07

MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer

50 enrolled

Breast Neoplasms

NCT00027885 2013-06-17

Phase II Bevacizumab + Tax In Advanced Breast Cancer

49 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00044993 2013-05-30

Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer

Breast Neoplasms, Breast Neoplasms, Male

NCT00072319 2013-03-04

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00645866 2011-05-16

Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer

47 enrolled

Breast Neoplasms

NCT00388115 2010-03-29

Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ

Phase NA Completed

15 enrolled